Epicillin (Dexacillin): a new semisynthetic penicillin: report of clinical experience.
D000081:Acetamides / Q000009:adverse effects / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D000368:Aged; D002177:Candidiasis; D002648:Child; D003510:Cyclohexanes / Q000009:adverse effects / Q000627:therapeutic use; D003967:Diarrhea / Q000139:chemically induced; D004415:Dyspepsia / Q000139:chemically induced; D005260:Female; D006069:Gonorrhea / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D010397:Penicillanic Acid / Q000009:adverse effects / Q000627:therapeutic use; D010406:Penicillins / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D011539:Pruritus Vulvae / Q000139:chemically induced; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D014552:Urinary Tract Infections / Q000188:drug therapy*; D014627:Vaginitis / Q000139:chemically induced
D000081:Acetamides; D003510:Cyclohexanes; D010406:Penicillins; D010397:Penicillanic Acid